Efficacy and safety of Xian-Lian-Jie-Du optimization decoction as an adjuvant treatment for prevention of recurrence in patients with stage IIIB/IIIC colon cancer: study protocol for a multicentre, randomized controlled trial
Abstract Introduction Colon cancer remains one of the most prevalent cancers worldwide. Unfortunately, there are no recognized and effective therapeutic strategies to prevent tumor recurrence after radical resection and chemotherapy, and the disease-free survival (DFS) in patients with stage IIIB or...
Saved in:
Main Authors: | Xuechen Geng (Author), Ziqiang Wang (Author), Li Feng (Author), Yanhong Gu (Author), Renjie Wang (Author), Qinghua Yao (Author), Yangxian Xu (Author), Jianyu Wu (Author), Zhiwei Jiang (Author), Kai Chen (Author), Wenwei Hu (Author), Dongxin Tang (Author), Jiege Huo (Author), Ling Li (Author), Qianqian Bu (Author), Shuoqi Zhao (Author), Bei Zhang (Author), Haibo Cheng (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of Significant Modules and Targets of Xian-Lian-Jie-Du Decoction Based on the Analysis of Transcriptomics, Proteomics and Single-Cell Transcriptomics in Colorectal Tumor
by: Yu CT, et al.
Published: (2022) -
Intermodule Coupling Analysis of Huang-Lian-Jie-Du Decoction on Stroke
by: Pengqian Wang, et al.
Published: (2019) -
Huang-Lian Jie-Du decoction: a review on phytochemical, pharmacological and pharmacokinetic investigations
by: Yiyu Qi, et al.
Published: (2019) -
A deletion of <it>FGFR2 </it>creating a chimeric IIIb/IIIc exon in a child with Apert syndrome
by: Klatt Regan EM, et al.
Published: (2011) -
Analysis of Antidepressant Activity of Huang-Lian Jie-Du Decoction Through Network Pharmacology and Metabolomics
by: Shu-Yue Qu, et al.
Published: (2021)